Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49]
Usd: 385 Special Discount
Specification
Safety datasheet
Overview
Product Name
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human Bcl-2 aa 1-233.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IHC-P, FC, IP
Molecular Weight
Predicted band size: 26 kDa
Positive Control
HeLa cell lysate, 293T cell lysate, NIH/3T3 cell lysate, RAW264.7 cell lysate, C2C12 cell lysate, Mouse kidney tissue lysate, Rat spleen tissue lysate, Rat kidney tissue lysate, mouse spleen tissue, mouse kidney tissue, PC-12.
Conjugation
unconjugated
Clone Number
PSH09-49
Reactivity Data
Tested Verified (internally validated)
Published Reported in literature (not internally validated)
Predicted Predicted reactive (based on sequence homology)
Not recommended Not recommended (failed internal validation)
| WB | IF-Cell | IHC-P | FC | IP | |
|---|---|---|---|---|---|
| Human |
|
|
|
|
|
| Mouse |
|
|
|
|
|
| Rat |
|
|
|
|
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IF-Cell
-
1:500
-
IHC-P
-
1:200
-
FC
-
1:1,000
-
IP
-
1-2μg/sample
Target
Function
Bcl-2 is one among many key regulators of apoptosis, which are essential for proper development, tissue homeostasis, and protection against foreign pathogens. Human Bcl-2 is an anti-apoptotic, membrane-associated oncoprotein that can promote cell survival through protein-protein interactions with other Bcl-2 related family members, such as the death suppressors Bcl-xL, Mcl-1, Bcl-w, and A1 or the death agonists Bax, Bak, Bik, Bad, and Bid. The anti-apoptotic function of Bcl-2 can also be regulated through proteolytic processing and phospho-rylation. Bcl-2 may promote cell survival by interfering with the activation of the cytochrome c/Apaf-1 pathway through stabilization of the mitochondrial membrane. Mutations in the Bcl-2 gene can contribute to cancers where normal physiological cell death mechanisms are compromised by deregulation of the anti-apoptotic influence of Bcl-2.
Background References
1. Cao LH et al. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts. Sci Rep 6:18706 (2016).
2. Chen B et al. Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells. Mol Med Rep 13:2527-35 (2016).
Subcellular Location
Mitochondrion outer membrane, Nucleus membrane, Endoplasmic reticulum membrane, Cytoplasm.
Synonyms
Apoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
ExpandApoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
D630044D05Rik antibody
D830018M01Rik antibody
Leukemia/lymphoma, B-cell, 2 antibody
Oncogene B-cell leukemia 2 antibody
PPP1R50 antibody
Protein phosphatase 1, regulatory subunit 50 antibody
Bcl 2 antibody
CollapseImages
-
Western blot analysis of Bcl-2 on different lysates with Rabbit anti-Bcl-2 antibody (HA723111) at 1/2,000 dilution.
Lane 1: HeLa cell lysate (20 µg/Lane)
Lane 2: 293T cell lysate (20 µg/Lane)
Lane 3: NIH/3T3 cell lysate (20 µg/Lane)
Lane 4: RAW264.7 cell lysate (20 µg/Lane)
Lane 5: C2C12 cell lysate (20 µg/Lane)
Lane 6: Mouse kidney tissue lysate (40 µg/Lane)
Lane 7: Rat spleen tissue lysate (40 µg/Lane)
Lane 8: Rat kidney tissue lysate (40 µg/Lane)
Predicted band size: 26 kDa
Observed band size: 25 kDa
Exposure time: Lane 1-6: 20 seconds; Lane 7-8: 3 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723111) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded mouse spleen tissue with Rabbit anti-Bcl-2 antibody (HA723111) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA723111) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Rabbit anti-Bcl-2 antibody (HA723111) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA723111) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of PC-12 cells labeling Bcl-2 with Rabbit anti-Bcl-2 antibody (HA723111) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Bcl-2 antibody (HA723111) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of PC-12 cells labeling Bcl-2.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA723111, 1μg/mL) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Bcl-2 was immunoprecipitated from 0.2 mg NIH/3T3 cell lysate with HA723111 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using HA723111 at 1/1,000 dilution. Mouse anti Rabbit IgG heavy chain (Fc) secondary antibody (M1003-7) at 1/10,000 dilution was used for 1 hour at room temperature.
Lane 1: NIH/3T3 cell lysate (input)
Lane 2: HA723111 IP in NIH/3T3 cell lysate
Lane 3: Rabbit IgG instead of HA723111 in NIH/3T3 cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 14 seconds; ECL: K1801
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Liuwei Dihuang Pills Suppress Hepatocellular Carcinoma via PI3K/AKT/TP53 Pathway: Integrating Network Pharmacology, Metabolomics, and Experimental Validation
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157780
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Inflammation-responsive DNA hydrogel integrating probiotic outer membrane vesicles for infection monitoring and precision therapy of diabetic wounds
Journal: Journal Of Controlled Release
DOI: 10.1016/j.jconrel.2025.114594
IF: 11.5
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Crotalaria assamica Benth alleviated acetaminophen-induced liver injury through the upregulation of Nrf2 pathway
Journal: JOURNAL OF ETHNOPHARMACOLOGY
DOI: 10.1016/j.jep.2025.120664
IF: 5.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Exosomes derived from human umbilical cord mesenchymal stem cells attenuate hepatic ischaemia-reperfusion injury via the let-7i-5p/Faslg axis
Journal: WORLD JOURNAL OF GASTROENTEROLOGY
DOI: 10.3748/wjg.v31.i33.108653
IF: 5.4
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Sept
-
Apelin-13 treats postmenopausal osteoporosis by reducing mitochondrial oxidative phosphorylation and modulating the OPG/RANK/RANKL/IGF-1 pathway
Journal: Biochemical And Biophysical Research Communications
DOI: 10.1016/j.bbrc.2025.152738
IF: 2.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Integrated Network Pharmacology and Experimental Study on Shikonin-Induced Male Reproductive Toxicity
Journal: Journal Of Applied Toxicology
DOI: 10.1002/jat.4959
IF: 2.8
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Oct
-
Integrated multi-omics elucidates PRNP knockdown-mediated chemosensitization to gemcitabine in pancreatic ductal adenocarcinoma
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2025.1667835
IF: 5.9
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Linderane from Lindera aggregata Attenuates Ulcerative Colitis by Suppressing IL-6/STAT3-Mediated Th17 Differentiation and Apoptosis Resistance
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120965
IF: 5.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Nov
-
1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation
Journal: Bioorganic Chemistry
DOI: 10.1016/j.bioorg.2025.109210
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Targeting miR-144-5p/ACSM1 Axis Alleviates Doxorubicin-Induced Heart Failure by Inhibiting Lipid Peroxidation
Journal: Current Medical Science
DOI: 10.1007/s11596-025-00053-z
IF: 2
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 May
-
Rebastinib attenuates acute lung injury by promoting NLRP3 ubiquitination and blocking NLRP3/GSDMD signaling pathway in macrophages and protecting alveolar epithelial cells
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.114819
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Highly Soluble Mussel Foot Protein Enhances Antioxidant Defense and Cytoprotection via PI3K/Akt and Nrf2/HO-1 Pathways
Journal: Antioxidants
DOI: 10.3390/antiox14060644
IF: 6
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Ursolic and oleanolic acids suppress MNNG induced malignant transformation of human gastric mucosal epithelium by regulating the PI3 K/AKT pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-025-03606-3
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Gata3 drives miR-21-5p transcription to mitigate hyperoxia-induced lung injury, independent of CpG Island methylation
Journal: Scientific Reports
DOI: 10.1038/s41598-025-09039-2
IF: 3.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
ELAVL1 interacts with APP and promotes Aβ-induced apoptosis in Alzheimer's disease by activating Bcl-2/Bax signaling
Journal: Experimental Neurology
DOI: 10.1016/j.expneurol.2025.115613
IF: 4.2
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Dec
-
Sodium butyrate attenuates sodium fluoride-induced cardiac injury in rats via modulating oxidative stress, inflammation, and apoptosis
Journal: Scientific Reports
DOI: 10.1038/s41598-025-31105-y
IF: 3.9
Application: WB
Reactivity: Rat
Publish date: 2025 Dec
-
Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming
Journal: Journal of Colloid and Interface Science
DOI: 10.1016/j.jcis.2025.139625
IF: 9.7
Application: WB
Reactivity: Human
Publish date: 2025 Dec
Products with the same target and pathway
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02] - BSA and Azide free
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Mouse Monoclonal Antibody [9F3-R]
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [SZ10-03] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [9F1]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02]
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [9F3]
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Mouse Monoclonal Antibody [9F3-R] - BSA and Azide free
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49] - BSA and Azide free
Application: WB,IF-Cell,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [SZ10-03]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PD01-41]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [F7-1-A1]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
FITC Conjugated Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8]
Application: FC
Reactivity: Human,Mouse
Conjugate: FITC